Abstract
BackgroundAdvancement in multiplex immunohistochemistry (mIHC) allows for single-cell tumor microenvironment analysis, greatly enhancing our comprehension of cancer immunology.1 However, clinical application of mIHC remains challenging due to technical variations and...
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have